Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients Who Receive Neoadjuvant Chemotherapy : Expanded Access Clinical Study in 3 Arms

NCT06212440 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT06212440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06212440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients Who Receive Neoadjuvant Chemotherapy : Expanded Access Clinical Study in 3 Arms
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Completed
Start date
May 4, 2021
Completion date
October 2, 2024
Enrollment
348 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm, neoadjuvant therapy, sentinel lymph node biopsy